- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/74 - Major histocompatibility complex [MHC]
Patent holdings for IPC class C07K 14/74
Total number of patents in this class: 1928
10-year publication summary
|
77
|
90
|
113
|
173
|
225
|
228
|
278
|
241
|
203
|
112
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1156 |
526 |
| Cue Biopharma, Inc. | 186 |
95 |
| CRISPR Therapeutics AG | 367 |
55 |
| Regeneron Pharmaceuticals, Inc. | 4303 |
55 |
| University Health Network | 1047 |
29 |
| 10X Genomics, Inc. | 1239 |
23 |
| Board of Regents, The University of Texas System | 5828 |
18 |
| The Regents of the University of California | 20015 |
17 |
| Imcyse SA | 73 |
15 |
| Sangamo Therapeutics, Inc. | 418 |
15 |
| Sana Biotechnology, Inc. | 155 |
15 |
| Ecole Polytechnique Federale de Lausanne (epfl) | 1543 |
14 |
| Oregon Health & Science University | 764 |
14 |
| Universite de Montreal | 341 |
14 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 310 |
13 |
| UTi Limited Partnership | 451 |
12 |
| Immunocore Limited | 216 |
11 |
| Xyphos Biosciences Inc. | 34 |
11 |
| Dana-Farber Cancer Institute, Inc. | 2574 |
10 |
| Julius-maximilians-universitat Wurzburg | 275 |
10 |
| Other owners | 956 |